IP Library Granted Patent US 11,834,471
Granted Patent B2
US 11,834,471 · App. 17/979,490 · Granted Dec 5, 2023

Iron compositions and methods of making and using the same

Inventors: Donald Jeffrey Keyser (Southlake, TX); Alvaro F. Guillem (Lantana, TX); Richard A. Zager (Seattle, WA)
Assignee: Renibus Therapeutics, Inc.
C07H23/00A61K9/0019A61K9/08A61K31/409
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,834,471
App. No.
17/979,490
Granted
Dec 5, 2023
Kind
B2
Abstract

The present invention involves a novel aqueous iron composition. The aqueous iron composition includes iron sucrose and bicarbonate. The aqueous iron composition of the invention exhibits enhanced renal protective effects relative to conventional iron sucrose compositions.

Claims (8)

1. An aqueous iron pharmaceutical composition comprising:

iron sucrose;

bicarbonate; and

a pharmaceutically acceptable aqueous carrier,

wherein the iron sucrose is present in pharmaceutically effective amount for providing a protective effect to a patient's kidney, the iron being present in both iron (II) and iron (Ill) form, the pharmaceutical composition has a pH greater than 9, a concentration of iron (II) of 0.05% w/v to 0.41% w/v, and the iron sucrose has a Mw according to GPC of between 33,000 and 38,000 Daltons.

2. The aqueous iron composition of claim 1 , wherein the composition has a specific gravity between 1.135 and 1.165 at 20° C.

3. The aqueous iron composition of claim 1 , wherein the composition has a concentration of iron (II) of 0.10% w/v to 0.20% w/v.

4. The aqueous iron composition of claim 1 , wherein the pH is within the range of 10.1 to 10.4.

Assignments (2)
SECURITY INTEREST Recorded Jun 4, 2026
From: RENIBUS THERAPEUTICS, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 074858/0020 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2023
From: KEYSER, DONALD JEFFREY; GUILLEM, ALVARO F.; ZAGER, RICHARD A.
To: RENIBUS THERAPEUTICS, INC.
Reel/Frame 062828/0087 →
Continuity (4)
Continuation 17672072 · Feb 15, 2022
Continuation 16805223 · Feb 28, 2020
Provisional Application 62812028 · Feb 28, 2019
Related Publication 20230070012A1 · Mar 9, 2023